BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 3, 2010
View Archived Issues
Clinical data presented on rituximab in ANCA-associated vasculitis and SLE
Read More
Agennix discloses interim data from first-in-human trial of RGB-286638 in hematologic tumors
Read More
Chugai Pharma presents in vivo data on new potential cancer therapeutics
Read More
Thioketal nanoparticles deliver siRNA against TNF-alpha to inflamed intestines in colitis model
Read More
Elorac's naloxone lotion receives FDA orphan drug status in CTCL-associated pruritus
Read More
Neuraltus reports topline phase I data on NP-001 in ALS
Read More
Enrollment complete in phase III edoxaban trial for stroke prevention in AF
Read More
Hana Biosciences becomes Talon Therapeutics
Read More
Phase IIb trial of PT-003 in COPD meets primary efficacy endpoint
Read More
AstraZeneca identifies novel dipeptidyl peptidase 1 inhibitors
Read More
Spanish scientists patent new bivalent pyrazole derivatives
Read More
Novartis claims new inhibitors of sodium/glucose cotransporters
Read More
CardioVascular BioTherapeutics licenses phase II data for FGF-1
Read More
FDA approves Octaplex IND and grants fast track status
Read More
Scientists use [18F]-FDG PET-CT scan for early detection of cancer in subjects with LFS
Read More
GenSpera adds trial site to G-202 phase I clinical program
Read More
AMT and Amgen amend licencing agreement for GDNF gene therapies
Read More
Tolerx and the Cancer Research Institute partner for TRX-518
Read More
FDA provides complete response letter to GSK and Valeant for ezogabine
Read More
Shire reports efficacy and safety results from FAST-3 study of icatibant
Read More
Ascenta Therapeutics and Ascentage Pharma form alliance for cancer programs
Read More
Argos doses patients in phase IIb Arcelis personalized HIV immunotherapy trial
Read More
Michael J. Fox Foundation awards Allon grant for Parkinson's disease research
Read More
Gradient Echo Plural Contrast Imaging monitors progression of MS
Read More
TAvi6, a bispecific antibody targeting VEGF-A/ANG-2 inhibits angiogenesis in vivo
Read More
